GLP-1 Drugs and Osteoarthritis: Miracle or Mess?

We’re not completely anti-drug.

Sometimes, the benefits of a medication outweigh the risks. If you’re obese, for example, GLP-1 drugs like semaglutide, can help lower your risk for diabetes, heart disease, and other life-threatening conditions.

And we won’t argue that getting your weight under control can be life-changing.

But we will argue that you deserve to know all the risks—before Big Pharma tries to sell you another “miracle cure.”

Well, now, these weight loss drugs are being pushed for osteoarthritis (OA)—and while some data suggests they help, other research suggests they could actually make things worse.

So, which is it?

There’s no doubt that losing weight relieves pressure on your joints.

Less weight means less wear and tear on your knees and hips. Fat cells also fuel inflammation, which worsens arthritis pain. And in many cases, shedding pounds naturally improves OA symptoms.

GLP-1 drugs absolutely help with weight loss. In fact, one major study (STEP 9) found that semaglutide users with knee OA had significantly reduced pain compared to a placebo.

But here’s where it gets tricky…

Not all studies agree that GLP-1s are a win for joint health.

A large-scale study of 2 million U.S. veterans found that people on GLP-1 drugs reported higher rates of joint pain and arthritis.

And another five-year study from Cleveland Clinic suggests that GLP-1 users with diabetes had a significantly higher risk of developing OA.

So what’s going on here?

• Muscle Loss – These drugs burn fat, but they also burn muscle—and muscle is crucial for joint support. If you’re losing muscle alongside fat, your joints may actually suffer more in the long run.
• Metabolic Changes – GLP-1 drugs alter how your body processes energy. Some experts believe this could affect cartilage health, potentially accelerating joint damage.
• Long-Term Unknowns – The biggest issue? We don’t have long-term data. Many OA patients will need to take these drugs indefinitely, and we simply don’t know what happens after years of use.

So, should you take a GLP-1 drug for OA?

It depends.

If you’re significantly overweight and struggling with joint pain, losing weight could dramatically improve your OA symptoms.

But if you’re only mildly overweight and looking for a quick fix, the risks may not be worth it.

If you already have OA and are considering these drugs, be aware of the potential trade-offs.

Right now, we’re missing critical long-term data—and Big Pharma isn’t waiting for it before pushing these drugs.

Big Pharma loves a one-size-fits-all drug solution—but when it comes to joint health, movement, muscle strength, and inflammation all matter just as much as weight loss.

Here’s what we recommend before turning to GLP-1s for OA:

• Prioritize natural weight loss – Regular movement, strength training, and a low-inflammatory diet are still the best ways to reduce OA pain.
• Support your joints with muscle-building exercises – Keeping your muscles strong prevents joint strain and supports cartilage health.
• Consider natural anti-inflammatory solutions – Turmeric, fish oil, and collagen supplements have all been shown to support joint health naturally—without the risks.

If you’re already taking or considering a GLP-1, talk to your doctor and ask the hard questions.

Because one thing is clear: the full story on these drugs hasn’t been written yet.

To weighing your options,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

Sources:

Tucker, M. E. (2025, March 17). Conflicting Data Leave Some Doubt About OA Role for GLP-1s. Medscape. https://www.medscape.com/viewarticle/conflicting-data-leave-some-doubt-about-oa-role-glp-1s-2025a10006dj